Current Headlines

  1. Amino Launches New German-Made L-Methionine Amino Acid For Pharmaceutical And Nutritional Applications

    Amino GmbH recently launched L-methionine amino acid as a safe and effective active pharmaceutical ingredient and nutritional substance.

  2. Veeva Systems Now Ranked Among The Top Three Most Preferred Software Vendors In IDC Life Sciences Spending Survey

    Veeva Systems is among the top three most preferred life sciences software vendors, according to IDC Health Insights’ Leading Indicators in Life Sciences IT Spending Survey[i], which measures planned investments for 2015.

  3. Astrazeneca Presents Positive Data On Azd9291 In First-Line Egfr Mutated Lung Cancer

    AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC). 

  4. Sobi Establishes Global Commercial Operations In The Cloud With Best-In-Class Veeva Commercial Cloud

    Sobi, a specialty life sciences company dedicated to rare diseases, has selected Veeva Commercial Cloud to support its global commercial organization across sales, marketing, and medical.

  5. EMD Millipore Launches Cellvento CHO Cell Culture Media Platform For Optimized Cell Growth And Productivity

    EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, recently announced the launch of its CellventoTMCHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.

  6. Veeva Systems Expands Healthcare Professional And Organization Data Offering For France

    Veeva Systems announced the availability of Veeva OpenData in France – the second European market in just six months – delivering a new approach to data that is open, easy, and global.

  7. Stem Cell Treatment Speeds Up Recovery after Spinal Cord Injury in Monkeys
  8. New drug discovery company announces $4m Series-A funding to tackle chronic respiratory disease

    ENTERPRISE THERAPEUTICS Ltd, a drug discovery company focused on new therapeutics for respiratory diseases, today announced that it has secured an additional £2.4m ($3.6m) in Series-A financing.

  9. EMD Millipore Introduces Single-Pass Tangential Flow Filtration With Pellicon Cassettes For Increased Capacity, Recovery And Concentration

    EMD Millipore, the Life Science business ofMerck KGaA of Darmstadt, Germany, recently introduced single-pass tangential flow filtration (TFF) with Pellicon cassettes, an enhanced application of EMD Millipore's existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.

  10. Global Vision Announces The Release Of DocuProof 3.1.0
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.